Furthermore, CLIP cells require epidermal growth factor receptor signalling to proliferate, and inhibition of EGFR can revert the TSC phenotype, suggesting a potential pathway for therapeutic intervention. This evidence concerns the gene EGFR and tuberous sclerosis.